Compliance Difficulties in Atopic Children, Reflections from an Eczema School in Sweden

Atopic dermatitis is one of the most common skin disorders in the developed world, affecting up to 20% of children and 1% to 3% of adults. This review concisely explains the pathophysiology and epidemiology of atopic dermatitis, as well as potential challenges facing its successful treatment. Furthermore, mainstay topical treatment modalities are evaluated, such as emollients, topical corticosteroids, and topical calcineurin inhibitors. The use of topical corticosteroids and topical calcineurin inhibitors in combination is discussed, as studies have indicated encouraging results. The proactive use of topical corticosteroids and topical calcineurin inhibitors is also investigated, in order to bring attention to a new possibility in long-term management of atopic dermatitis. Last, new and upcoming topical medications are described, including Janus kinase inhibitors, phosphodiesterase-4 inhibitors, and benvitimod. Although topical corticosteroids and topical calcineurin inhibitors can be very effective in the treatment of atopic dermatitis, it is important that practitioners are aware of mechanistically unique and new treatments for patients for whom more traditional topical therapies have failed. Overall, this review article hopes to serve as a comprehensive overview of currently available topical treatments for atopic dermatitis, while shedding light on new treatments coming in the future.

show abstract

“…This is where the value of having a comprehensive team comes into play, as many of these issues can be explored. 22…”

Section: Challenges Facing Topical Therapymentioning

confidence: 99%

Review of Atopic Dermatitis and Topical Therapies

Mayba

Gooderham

2016

J Cutan Med Surg

View full text Add to dashboard Cite

show abstract

Management of Atopic Dermatitis in Children: A Pediatrician State of the Art

Vujnović¹,

Domuz²

2018

Corticosteroids

View full text Add to dashboard Cite

Atopic dermatitis (AD) is one of the most common skin conditions in children and adolescents. This disease is characterized by acute and chronic lesions. Acute lesions can occur at any age and have a recurring character. Localization of acute lesions is a characteristic for a certain age of the child. Chronic lesions are present after the second year of life and characterized by pruritus and lichenification. Ichthyosis and xerosis are also characteristics of chronic lesions. The authors represent two hypotheses about pathophysiology of atopic dermatitis: "inside-out" hypothesis suggests that pathophysiological process is the result of an inflammatory response, while the "outside-inside" hypothesis suggests that changes of the epidermal barrier are responsible for the process in lesions in atopic dermatitis. There is no gold standard, clinical or laboratory, for the diagnosis of atopic dermatitis. The diagnosis should be based on anamnesis, clinical features and laboratory results. The therapeutic approach includes general and specific measures. General measures including topical moisturizers, bathing and bathing practices and wet-wrap therapy. Specific measures include topical corticosteroids and topical calcineurin inhibitors. Systemic immunosuppressant agents and phototherapy are a second-line treatment and used when the atopic dermatitis is not controlled. These patients must be treated by a dermatologist or pediatricians.

show abstract

Compliance Difficulties in Atopic Children, Reflections from an Eczema School in Sweden

Cited by 2 publications

References 27 publications

Review of Atopic Dermatitis and Topical Therapies

Review of Atopic Dermatitis and Topical Therapies

Management of Atopic Dermatitis in Children: A Pediatrician State of the Art

Contact Info

Product

Resources

About